GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Future 3-5Y EPS without NRI Growth Rate

4basebio (LSE:4BB) Future 3-5Y EPS without NRI Growth Rate : -14.78 (As of May. 14, 2025)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, 4basebio's Future 3-5Y EPS without NRI Growth Rate is -14.78.

Competitive Comparison of 4basebio's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, 4basebio's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4basebio's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where 4basebio's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

4basebio  (LSE:4BB) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

4basebio Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of 4basebio's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
LSE:IBT LSE:BVXP LSE:AVCT LSE:FARN LSE:HVO LSE:SCLP LSE:SBTX LSE:PRTC LSE:OBI LSE:OXB VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
88Q:Germany
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
Website
https://www.4basebio.com
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio Headlines

No Headlines